Quantcast

Latest dialysis Stories

2014-07-20 23:00:20

The Firm is actively filing NaturaLyte and GranuFlo lawsuits on behalf of dialysis patients who allegedly suffered strokes, heart attacks and other cardiovascular problems after being administered the medications. New York, NY (PRWEB) July 20, 2014 Nearly 2,000 NaturaLyte and GranuFlo lawsuits (http://www.thegranuflolawsuit.com ) have now been filed in a federal litigation involving the dialysis medications, Bernstein Liebhard LLP reports. A Case List updated on July 15th indicates that...

2014-07-17 16:26:20

Analysis Shows Study Met Primary and All Secondary Endpoints THOUSAND OAKS, Calif., July 17, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that a Phase 3 study evaluating AMG 416 (formerly known as velcalcetide) for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, met its primary and all secondary endpoints. The primary endpoint was the proportion of patients with > 30 percent reduction from...

2014-07-16 12:27:25

NxStage Patient Advocates to travel the East Coast to share the benefits of home hemodialysis LAWRENCE, Mass., July 16, 2014 /PRNewswire/ -- NxStage® Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, announced today the launch of the NxStage Freedom Tour, a two week road trip in a recreational vehicle to promote and educate dialysis patients on the benefits of home hemodialysis with the NxStage System One(TM). Traveling in the NxStage Freedom...

2014-07-11 12:24:32

Hospital successfully transplants the first liver dialysis patient in the state HOUSTON, July 11, 2014 /PRNewswire-USNewswire/ -- Texas Children's Hospital is excited to announce the first use of an extracorporeal liver support therapy in Texas for children with acute liver failure. The hospital now offers the Molecular Adsorbent Recirculating System (MARS®), a liver dialysis therapy, which helped a 9-year-old patient with hepatic coma become healthy enough to be a candidate for...

2014-07-10 12:28:45

Interest in GCS-100, Velcalcetide, ST-10, GSK-1278863A and Rayaldee Ranges from Moderate to High, According to Findings from Decision Resources Group BURLINGTON, Mass., July 10, 2014 /PRNewswire/ -- Decision Resources Group finds that over half of surveyed nephrologists report awareness of the U.S. Food and Drug Administration's (FDA) approval of Vifor Fresenius Medical Care Renal Pharma's new phosphate binder Velphoro, which was approved by the FDA in November 2013 for the treatment of...

2014-07-10 04:21:24

STOCKHOLM, July 10, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, has had core patents for its late-stage clinical candidate Nefecon(R) issued in the key markets United States, Europe, China and Hong Kong. A patent is pending in Japan. Nefecon is a potential disease-modifying treatment for patients with primary IgA nephropathy at risk of developing end-stage renal disease. Nefecon has shown positive results in an...

2014-07-09 08:27:28

World-class Nephrologist to Lead Home Dialysis Program DENVER, July 9, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company has named Martin Schreiber, M.D., as its new vice president of clinical affairs for home modalities. http://photos.prnewswire.com/prnvar/20140303/LA75036LOGO-b DaVita's home hemodialysis (HHD) and peritoneal dialysis (PD)...

2014-07-08 23:01:41

The Firm is representing numerous GranuFlo lawsuit clients who allegedly suffered catastrophic heart events due to the use of GranuFlo or NaturaLyte dialysis concentrates. New York, New York (PRWEB) July 08, 2014 GranuFlo lawsuits (http://www.thegranuflolawsuit.com) filed in the wake of the 2012 GranuFlo and NaturaLyte dialysis concentrate recall continue to move forward in courts throughout the U.S., Bernstein Liebhard LLP reports. According to court documents filed on July 3rd, a...

2014-07-08 08:31:07

Special Guest Recording Artist and Former NxStage System One patient, David RUSH LAWRENCE, Mass., July 8, 2014 /PRNewswire/ -- WHAT: NxStage Kidney Care will be hosting a Grand Opening celebration and ribbon cutting reception for its new state-of-the- art dialysis center in Jacksonville, Florida. The Grand Opening event, which is open to the public, will include a ribbon cutting reception, tours of the 6,300 sq. ft. facility, and an opportunity to...

2014-07-04 23:02:00

Fresenius Medical Care North America Recalls 56 Lots of Liquid Bicarbonate Concentrate DALLAS (PRWEB) July 04, 2014 Fresenius Medical Care North America, manufacturer of the dialysis drugs GranuFlo and NaturaLyte, has recalled 56 lots of NaturaLyte due to finding higher bacteria levels than allowed by internal specifications. The company is involved in litigation in a Massachusetts federal court where more than 1,700 lawsuits have been filed in conjunction with a previous recall. (In Re:...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related